HIV Stocks List

Related ETFs - A few ETFs which own one or more of the above listed HIV stocks.

HIV Stocks Recent News

Date Stock Title
May 10 OSUR OraSure Technologies First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
May 10 NNVC NanoViricides to Participate in the 2024 EF Hutton Annual Global Conference On May 15 in New York City
May 9 OSUR OraSure Technologies, Inc. (NASDAQ:OSUR) Q1 2024 Earnings Call Transcript
May 9 RPRX Royalty Pharma PLC (RPRX) Q1 2024 Earnings Call Transcript
May 9 GSK Top 5 Health Care Stocks That Could Sink Your Portfolio In Q2
May 9 OSUR Q1 2024 OraSure Technologies Inc Earnings Call
May 9 LH We Think Shareholders May Want To Consider A Review Of Laboratory Corporation of America Holdings' (NYSE:LH) CEO Compensation Package
May 9 RPRX Royalty Pharma reports Q1 results
May 9 RPRX Royalty Pharma Reports First Quarter 2024 Results
May 9 RPRX Royalty Pharma to Acquire Royalty Interest in Sanofi’s Frexalimab
May 9 GSK Moderna’s First Vaccine Was a Big Hit. Its Second Is a Let Down
May 9 OSUR OraSure Technologies Inc (OSUR) Q1 2024 Earnings Call Transcript Highlights: Strategic ...
May 9 GSK GSK (LON:GSK) Is Paying Out A Dividend Of £0.15
May 9 OSUR OraSure Technologies, Inc. (OSUR) Q1 2024 Earnings Call Transcript
May 8 OSUR OraSure Technologies (OSUR) Q1 Earnings Meet Estimates
May 8 OSUR OraSure Technologies Non-GAAP EPS of $0.04 beats by $0.01, revenue of $54.13M beats by $1.86M
May 8 OSUR OraSure Reports Q1 ’24 Revenue of $54.1 Million
May 8 RPRX Royalty Pharma Q1 2024 Earnings Preview
May 8 RPRX Teva, Medincell succeed in late-stage trial for injectable schizophrenia therapy
May 8 LH Labcorp to Webcast Its Annual Meeting of Shareholders
HIV

The human immunodeficiency virus (HIV) is a lentivirus (a subgroup of retrovirus) that causes HIV infection and over time acquired immunodeficiency syndrome (AIDS). AIDS is a condition in humans in which progressive failure of the immune system allows life-threatening opportunistic infections and cancers to thrive. Without treatment, average survival time after infection with HIV is estimated to be 9 to 11 years, depending on the HIV subtype. In most cases, HIV is a sexually transmitted infection and occurs by contact with or transfer of blood, pre-ejaculate, semen, and vaginal fluids. Non-sexual transmission can occur from an infected mother to her infant during pregnancy, during childbirth by exposure to her blood or vaginal fluid, and through breast milk. Within these bodily fluids, HIV is present as both free virus particles and virus within infected immune cells.
HIV infects vital cells in the human immune system, such as helper T cells (specifically CD4+ T cells), macrophages, and dendritic cells. HIV infection leads to low levels of CD4+ T cells through a number of mechanisms, including pyroptosis of abortively infected T cells, apoptosis of uninfected bystander cells, direct viral killing of infected cells, and killing of infected CD4+ T cells by CD8+ cytotoxic lymphocytes that recognize infected cells. When CD4+ T cell numbers decline below a critical level, cell-mediated immunity is lost, and the body becomes progressively more susceptible to opportunistic infections, leading to the development of AIDS.

Browse All Tags